Overview
New China Life Insurance Company Ltd., based in China, operates primarily within the insurance industry. The company is chiefly engaged in providing life insurance products and services, including individual and group life, health, and accident insurance policies. As a significant player in China’s insurance sector, it extends its services throughout various regions in the country, catering to a substantial client base. New China Life also focuses on investment activities pertinent to its insurance funds, emphasizing stable and long-term returns. Key projects include embracing digital transformation to enhance service delivery and customer engagement, involving the integration of advanced technologies such as artificial intelligence to streamline operations and improve risk management practices.
AI+ Ask Fintel’s AI assistant about New China Life Insurance Company Ltd..
Thinking about good questions…
Basic Stats
The share price of New China Life Insurance Company Ltd. as of 5 September 2025 is 4,94 € / share. This is a decrease of -5.90% from the prior week. The market cap (or net worth) of New China Life Insurance Company Ltd. as of 5 September 2025 is 5.108,49 € MM.
The Factor Analysis chart (below right) shows a view of New China Life Insurance Company Ltd. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 5,108.49 MM |
| EV | |
| Shares Out. | 3,119.55 MM |
| Earnings Date | |
| EPS (TTM) | 8.71 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.65 |
| Short Shares Avail. | 0.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 174.44 % |
| Volatility (1 yr) | 0.65 |
| Beta | 0.80 |
| Sharpe Ratio (1 yr) | 2.61 |
| Sortino Ratio (1 yr) | 4.47 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.02 |
| ROE | 0.30 |
| ROIC | 0.10 |
| CROIC | 0.06 |
| OCROIC | 0.34 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 49.90 /100 |
| Profitability | 85.76 /100 |
| Quality Score | 85.64 /100 |
| Value Score | |
| Momentum Score | 64.28 /100 |
| Stability (Low Vol) Score | 25.68 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 92.43 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for New China Life Insurance Company Ltd.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| No data available. | ||||
